Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
- > Lactobacillus acidophilus – LA02 (DSM 21717)
Lactobacillus acidophilus – LA02 (DSM 21717)
Discover characteristics, functionalities and scientific support of Lactobacillus acidophilus – LA02 (DSM 21717).
Thearapeutical Area(s): Gastrointestinal tract, Gut brain Axis, Urogenital system
Age/Gender: Adults, Elderly
Scientific reference(s)
Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice. J. Clin. Gastroenterol. Vol 42, Suppl. 3, Part 2, Sept. 2008. (LA02, LPC00).
Internal data in vitro on gut permeability protection and anti-inflammatory activity available upon request for LA02 at Probiotical.
Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.
Luca Magistrelli et al. Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence. Front. Immunol., 07 May 2019
+ Internal data on anti-inflammatory and anti-oxidant properties available upon request on certain strains at Probiotical.
